Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons

Ilya Buldyrev, Nathan M. Tanner, Hui Ya Hsieh, Emily G. Dodd, Loi T. Nguyen, Agnieszka Balkowiec

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Activity-dependent plasticity in nociceptive pathways has been implicated in pathomechanisms of chronic pain syndromes. Calcitonin gene-related peptide (CGRP), which is expressed by trigeminal nociceptors, has recently been identified as a key player in the mechanism of migraine headaches. Here we show that CGRP is coexpressed with brain-derived neurotrophic factor (BDNF) in a large subset of adult rat trigeminal ganglion neurons in vivo. Using ELISA in situ, we show that CGRP (1-1000 nm) potently enhances BDNF release from cultured trigeminal neurons. The effect of CGRP is dose-dependent and abolished by pretreatment with CGRP receptor antagonist, CGRP(8-37). Intriguingly, CGRP-mediated BDNF release, unlike BDNF release evoked by physiological patterns of electrical stimulation, is independent of extracellular calcium. Depletion of intracellular calcium stores with thapsigargin blocks the CGRP-mediated BDNF release. Using transmission electron microscopy, our study also shows that BDNF-immunoreactivity is present in dense core vesicles of unmyelinated axons and axon terminals in the subnucleus caudalis of the spinal trigeminal nucleus, the primary central target of trigeminal nociceptors. Together, these results reveal a previously unknown role for CGRP in regulating BDNF availability, and point to BDNF as a candidate mediator of trigeminal nociceptive plasticity.

Original languageEnglish (US)
Pages (from-to)1338-1350
Number of pages13
JournalJournal of Neurochemistry
Volume99
Issue number5
DOIs
StatePublished - Dec 2006

Fingerprint

Trigeminal Ganglion
Calcitonin Gene-Related Peptide
Brain-Derived Neurotrophic Factor
Neurons
Nociceptors
Plasticity
Spinal Trigeminal Nucleus
Calcitonin Gene-Related Peptide Receptors
Calcium
Thapsigargin
Presynaptic Terminals
Secretory Vesicles
Migraine Disorders
Transmission Electron Microscopy
Chronic Pain
Electric Stimulation
Axons
Rats
Enzyme-Linked Immunosorbent Assay
Availability

Keywords

  • Brain-derived neurotrophic factor
  • Calcitonin gene-related peptide
  • Migraine
  • Pain
  • Synaptic plasticity
  • Trigeminal

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons. / Buldyrev, Ilya; Tanner, Nathan M.; Hsieh, Hui Ya; Dodd, Emily G.; Nguyen, Loi T.; Balkowiec, Agnieszka.

In: Journal of Neurochemistry, Vol. 99, No. 5, 12.2006, p. 1338-1350.

Research output: Contribution to journalArticle

Buldyrev, Ilya ; Tanner, Nathan M. ; Hsieh, Hui Ya ; Dodd, Emily G. ; Nguyen, Loi T. ; Balkowiec, Agnieszka. / Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons. In: Journal of Neurochemistry. 2006 ; Vol. 99, No. 5. pp. 1338-1350.
@article{51b43148a09a495295e11ee2e624ea27,
title = "Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons",
abstract = "Activity-dependent plasticity in nociceptive pathways has been implicated in pathomechanisms of chronic pain syndromes. Calcitonin gene-related peptide (CGRP), which is expressed by trigeminal nociceptors, has recently been identified as a key player in the mechanism of migraine headaches. Here we show that CGRP is coexpressed with brain-derived neurotrophic factor (BDNF) in a large subset of adult rat trigeminal ganglion neurons in vivo. Using ELISA in situ, we show that CGRP (1-1000 nm) potently enhances BDNF release from cultured trigeminal neurons. The effect of CGRP is dose-dependent and abolished by pretreatment with CGRP receptor antagonist, CGRP(8-37). Intriguingly, CGRP-mediated BDNF release, unlike BDNF release evoked by physiological patterns of electrical stimulation, is independent of extracellular calcium. Depletion of intracellular calcium stores with thapsigargin blocks the CGRP-mediated BDNF release. Using transmission electron microscopy, our study also shows that BDNF-immunoreactivity is present in dense core vesicles of unmyelinated axons and axon terminals in the subnucleus caudalis of the spinal trigeminal nucleus, the primary central target of trigeminal nociceptors. Together, these results reveal a previously unknown role for CGRP in regulating BDNF availability, and point to BDNF as a candidate mediator of trigeminal nociceptive plasticity.",
keywords = "Brain-derived neurotrophic factor, Calcitonin gene-related peptide, Migraine, Pain, Synaptic plasticity, Trigeminal",
author = "Ilya Buldyrev and Tanner, {Nathan M.} and Hsieh, {Hui Ya} and Dodd, {Emily G.} and Nguyen, {Loi T.} and Agnieszka Balkowiec",
year = "2006",
month = "12",
doi = "10.1111/j.1471-4159.2006.04161.x",
language = "English (US)",
volume = "99",
pages = "1338--1350",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons

AU - Buldyrev, Ilya

AU - Tanner, Nathan M.

AU - Hsieh, Hui Ya

AU - Dodd, Emily G.

AU - Nguyen, Loi T.

AU - Balkowiec, Agnieszka

PY - 2006/12

Y1 - 2006/12

N2 - Activity-dependent plasticity in nociceptive pathways has been implicated in pathomechanisms of chronic pain syndromes. Calcitonin gene-related peptide (CGRP), which is expressed by trigeminal nociceptors, has recently been identified as a key player in the mechanism of migraine headaches. Here we show that CGRP is coexpressed with brain-derived neurotrophic factor (BDNF) in a large subset of adult rat trigeminal ganglion neurons in vivo. Using ELISA in situ, we show that CGRP (1-1000 nm) potently enhances BDNF release from cultured trigeminal neurons. The effect of CGRP is dose-dependent and abolished by pretreatment with CGRP receptor antagonist, CGRP(8-37). Intriguingly, CGRP-mediated BDNF release, unlike BDNF release evoked by physiological patterns of electrical stimulation, is independent of extracellular calcium. Depletion of intracellular calcium stores with thapsigargin blocks the CGRP-mediated BDNF release. Using transmission electron microscopy, our study also shows that BDNF-immunoreactivity is present in dense core vesicles of unmyelinated axons and axon terminals in the subnucleus caudalis of the spinal trigeminal nucleus, the primary central target of trigeminal nociceptors. Together, these results reveal a previously unknown role for CGRP in regulating BDNF availability, and point to BDNF as a candidate mediator of trigeminal nociceptive plasticity.

AB - Activity-dependent plasticity in nociceptive pathways has been implicated in pathomechanisms of chronic pain syndromes. Calcitonin gene-related peptide (CGRP), which is expressed by trigeminal nociceptors, has recently been identified as a key player in the mechanism of migraine headaches. Here we show that CGRP is coexpressed with brain-derived neurotrophic factor (BDNF) in a large subset of adult rat trigeminal ganglion neurons in vivo. Using ELISA in situ, we show that CGRP (1-1000 nm) potently enhances BDNF release from cultured trigeminal neurons. The effect of CGRP is dose-dependent and abolished by pretreatment with CGRP receptor antagonist, CGRP(8-37). Intriguingly, CGRP-mediated BDNF release, unlike BDNF release evoked by physiological patterns of electrical stimulation, is independent of extracellular calcium. Depletion of intracellular calcium stores with thapsigargin blocks the CGRP-mediated BDNF release. Using transmission electron microscopy, our study also shows that BDNF-immunoreactivity is present in dense core vesicles of unmyelinated axons and axon terminals in the subnucleus caudalis of the spinal trigeminal nucleus, the primary central target of trigeminal nociceptors. Together, these results reveal a previously unknown role for CGRP in regulating BDNF availability, and point to BDNF as a candidate mediator of trigeminal nociceptive plasticity.

KW - Brain-derived neurotrophic factor

KW - Calcitonin gene-related peptide

KW - Migraine

KW - Pain

KW - Synaptic plasticity

KW - Trigeminal

UR - http://www.scopus.com/inward/record.url?scp=33750910190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750910190&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2006.04161.x

DO - 10.1111/j.1471-4159.2006.04161.x

M3 - Article

VL - 99

SP - 1338

EP - 1350

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 5

ER -